Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Maridebart Cafraglutide

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Amgen · Phase 2 · Active, not recruiting · Enrollment 180

NCT07441252

ArmPopulationDoseWeeksEstimandWeight change
Maridebart CafraglutideObesity or overweightn/r4n/rn/r
PlaceboObesity or overweightn/r4n/rn/r